Harmonizing mind acupuncture combined with nicotine replacement therapy reduces nicotine craving and increases abstinence in tobacco use disorder
This pragmatic randomized controlled trial will evaluate whether adding harmonizing mind acupuncture (HMA) to nicotine replacement therapy (NRT) improves outcomes in tobacco use disorder. The co-primary outcomes are change in nicotine craving (VAS) from baseline to week 6 and biochemically verified 7-day point prevalence abstinence at week 6. The trial will enroll 220 participants and follow them for 24 weeks.
Evidence Score
Study Evidence
Study 1. Harmonizing mind acupuncture combined with nicotine replacement therapy for tobacco use disorder: a protocol for a pragmatic randomized controlled trial.
observationalLi C, Wang B, Zhao S, Ruan Q, Pan L, Qiu M ยท Frontiers in public health (2026)
Result:
Mechanism Graph
Limitations
- โ Pragmatic design may introduce variability in treatment delivery
- โ Single-center study may limit generalizability
- โ No blinding due to nature of acupuncture intervention
Frequently Asked Questions
What is the primary outcome of this trial?โผ
The co-primary outcomes are change in nicotine craving measured by VAS from baseline to week 6 and biochemically verified 7-day point prevalence abstinence at week 6.
How many participants will be enrolled?โผ
A total of 220 participants with tobacco use disorder will be randomly assigned in a 1:1 ratio to receive HMA plus NRT or NRT alone.
What is the duration of the intervention and follow-up?โผ
The intervention period lasts 6 weeks, with follow-up extending to 24 weeks.
Is this study blinded?โผ
No, blinding is not mentioned; pragmatic trials often lack blinding due to the nature of the intervention.
Products
Affiliate links coming soon. We only recommend products that match the doses and forms used in the cited research.
References
- 1.Li C, Wang B, Zhao S, Ruan Q, Pan L, Qiu M. "Harmonizing mind acupuncture combined with nicotine replacement therapy for tobacco use disorder: a protocol for a pragmatic randomized controlled trial.." Frontiers in public health, 2026. PMID: 42534905 DOI: 10.3389/fpubh.2026.1850199